Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-039572
Date:2021-06-08
Issuer: SYROS PHARMACEUTICALS, INC. (SYRS)
Original Submission Date:

Reporting Person:

ALLES MARK J
C/O SYROS PHARMACEUTICALS, INC.
35 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 6.3 2021-06-08 deemed execution date A 17,500 (a) 2031-06-07 common stock 17,500 $6.30 17,500 direct
Footnotes
IDfootnote
f1 the option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.
WhaleWisdom Logo

Elevate your investments